Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation

Alexander Kogan*, Marius Berman, Ygal Kassif, Ehud Raanani, Alon Stamler, Tuvia Ben Gal, Michael Stein, Eldad Erez, Bernardo A. Vidne, Gideon Sahar

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Abstract

A 48-year-old man undergoing orthotopic heart transplantation for ischemic cardiomyopathy developed severe right heart failure. Severe intractable bleeding complicated implantation of a right ventricular assist device. Treatment with 9.6 mg of recombinant activated factor VII stopped the bleeding, and the patient could be transferred to the intensive care unit. This is the first reported case of the successful use of recombinant activated factor VII to control bleeding with subsequent right ventricular assist device function.

Original languageEnglish
Pages (from-to)347-349
Number of pages3
JournalJournal of Heart and Lung Transplantation
Volume24
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

Dive into the research topics of 'Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation'. Together they form a unique fingerprint.

Cite this